These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 34043900)

  • 41. Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.
    Al-Soleiti M; Balaj K; Thom RP; McDougle CJ; Keary CJ
    J Autism Dev Disord; 2022 Sep; 52(9):4164-4171. PubMed ID: 34505186
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.
    Siani-Rose M; Cox S; Goldstein B; Abrams D; Taylor M; Kurek I
    Cannabis Cannabinoid Res; 2023 Feb; 8(1):126-137. PubMed ID: 34874191
    [No Abstract]   [Full Text] [Related]  

  • 43. Dance intervention for negative symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis.
    Chen T; Wen R; Liu H; Zhong X; Jiang C
    Complement Ther Clin Pract; 2022 May; 47():101565. PubMed ID: 35259569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature.
    Nduma BN; Mofor KA; Tatang J; Ekhator C; Ambe S; Fonkem E
    Cureus; 2023 Mar; 15(3):e36148. PubMed ID: 37065370
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
    Wang L; Hong PJ; May C; Rehman Y; Oparin Y; Hong CJ; Hong BY; AminiLari M; Gallo L; Kaushal A; Craigie S; Couban RJ; Kum E; Shanthanna H; Price I; Upadhye S; Ware MA; Campbell F; Buchbinder R; Agoritsas T; Busse JW
    BMJ; 2021 Sep; 374():n1034. PubMed ID: 34497047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies.
    Fusar-Poli L; Cavone V; Tinacci S; Concas I; Petralia A; Signorelli MS; Díaz-Caneja CM; Aguglia E
    Brain Sci; 2020 Aug; 10(9):. PubMed ID: 32825313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incontinence in autism spectrum disorder: a systematic review.
    Niemczyk J; Wagner C; von Gontard A
    Eur Child Adolesc Psychiatry; 2018 Dec; 27(12):1523-1537. PubMed ID: 29019014
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis.
    Siafis S; Çıray O; Wu H; Schneider-Thoma J; Bighelli I; Krause M; Rodolico A; Ceraso A; Deste G; Huhn M; Fraguas D; San José Cáceres A; Mavridis D; Charman T; Murphy DG; Parellada M; Arango C; Leucht S
    Mol Autism; 2022 Mar; 13(1):10. PubMed ID: 35246237
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder.
    Rossignol DA; Frye RE
    J Pers Med; 2021 May; 11(6):. PubMed ID: 34070826
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials.
    McKee KA; Hmidan A; Crocker CE; Lam RW; Meyer JH; Crockford D; Trépanier A; Aitchison KJ; Tibbo PG
    J Psychiatr Res; 2021 Aug; 140():267-281. PubMed ID: 34119912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short report: Relationships between sensory processing, repetitive behaviors, anxiety, and intolerance of uncertainty in autism spectrum disorder and Williams syndrome.
    Glod M; Riby DM; Rodgers J
    Autism Res; 2019 May; 12(5):759-765. PubMed ID: 30919599
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Review of the Role of Prebiotics and Probiotics in Autism Spectrum Disorders.
    Ng QX; Loke W; Venkatanarayanan N; Lim DY; Soh AYS; Yeo WS
    Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31083360
    [No Abstract]   [Full Text] [Related]  

  • 53. Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents.
    Hurwitz R; Blackmore R; Hazell P; Williams K; Woolfenden S
    Cochrane Database Syst Rev; 2012 Mar; (3):CD008372. PubMed ID: 22419332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.
    Botsford SL; Yang S; George TP
    Am J Addict; 2020 Jan; 29(1):9-26. PubMed ID: 31577377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocannabinoid System Dysregulation from Acetaminophen Use May Lead to Autism Spectrum Disorder: Could Cannabinoid Treatment Be Efficacious?
    Schultz S; Gould GG; Antonucci N; Brigida AL; Siniscalco D
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33805951
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pain Experiences of People Diagnosed With Autism Spectrum Disorder: A Systematic Review of Case-Control Studies.
    Ortiz Rubio A; de María Romero Ayuso DN; Torres Sánchez I; Cabrera Martos I; Rodríguez Torres J; López López L; Valenza MC
    Am J Occup Ther; 2023 Mar; 77(2):. PubMed ID: 37040102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
    Sarris J; Sinclair J; Karamacoska D; Davidson M; Firth J
    BMC Psychiatry; 2020 Jan; 20(1):24. PubMed ID: 31948424
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zonulin-Dependent Intestinal Permeability in Children Diagnosed with Mental Disorders: A Systematic Review and Meta-Analysis.
    Asbjornsdottir B; Snorradottir H; Andresdottir E; Fasano A; Lauth B; Gudmundsson LS; Gottfredsson M; Halldorsson TI; Birgisdottir BE
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence and comorbidity of autism spectrum disorder in Spain: study protocol for a systematic review and meta-analysis of observational studies.
    Catalá-López F; Ridao M; Hurtado I; Núñez-Beltrán A; Gènova-Maleras R; Alonso-Arroyo A; Tobías A; Aleixandre-Benavent R; Catalá MA; Tabarés-Seisdedos R
    Syst Rev; 2019 Jun; 8(1):141. PubMed ID: 31200773
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lurasidone for the treatment of irritability and anger in autism spectrum disorders.
    McClellan L; Dominick KC; Pedapati EV; Wink LK; Erickson CA
    Expert Opin Investig Drugs; 2017 Aug; 26(8):985-989. PubMed ID: 28685626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.